Skip to main
NEOG
NEOG logo

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 0%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Neogen Corporation has strengthened its market position through a recent acquisition, enhancing its capabilities in food and animal safety sectors, which contributes positively to its growth outlook. The company's reliance on internal growth strategies complements its competitive advantages within the industry while navigating potential risks associated with supply chain disruptions. As Neogen continues to innovate and expand its product offerings in diagnostics and veterinary solutions, it is well-positioned for sustained performance in the rapidly evolving safety markets.

Bears say

Neogen Corporation is primarily involved in food and animal safety, with a diverse portfolio that includes diagnostics, veterinary products, and safety instruments; however, recent financial reports indicate declining revenue growth and profitability challenges. The company has faced increasing competition in its market segments, which has put pressure on profit margins and led to inefficiencies in operations. Additionally, rising costs associated with raw materials and labor, alongside a lack of robust demand in certain product categories, have further contributed to a negative financial outlook for Neogen.

Neogen (NEOG) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 0% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 3 analysts, Neogen (NEOG) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.